Clinical Trial Update: APOL1 Genotyping CTA Clinical Performance Study [NA]

View source ↗

Summary

Status update for a clinical trial evaluating APOL1 genotyping in APOL1-associated kidney disease; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Apol1-associated Kidney Disease

Snippet

Sponsor: Almac Diagnostic Services LLC | Conditions: APOL1-mediated Kidney Disease | NA | Status: RECRUITING